// App-Quantinova.ai

: Using a selective avß6 PET ligand to optimise early phase IPF clinical trials

Researchers

Presenter

  • Juliet Simpson

Principal Investigators

  • Arthur KangOmbe

  • Maria Costa

  • Frederick Wilson

  • William Fahy

  • Richard Marshall

  • Charlotte Maden

  • Christopher Coello

  • Azeem Saleem

  • David Fairman

  • Mitra Vahdati-Bolouri

  • Toby Maher

Medical Centers

  • GlaxoSmithKline Research & Development Ltd, Stevenage, United Kingdom

  • Invicro LLC, London, United Kingdom

  • NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, United Kingdom,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alphavbeta6 integrin (αvβ6 integrin)

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • I

Study Id's

  • NCT02052297

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved